Gender differences in SLE: report from a cohort of 417 Caucasian patientsFrancesca Trentin, Viola Signorini, Maria Laura Manca, Giancarlo Cascarano, Luca Gualtieri, Davide Schilirò, Anastasiya Valevich, Chiara Cardelli, Linda Carli, Elena Elefante, Francesco Ferro, Chiara Stagnaro, Dina Zucchi, Chiara Tani, Marta Mosca
25 April 2023
Infection-related hospitalisation in young adults with systemic lupus erythematosus: data from the National Inpatient SampleRashmi Dhital, Monica Guma, Dilli R Poudel, Christina Chambers, Kenneth Kalunian
5 April 2023
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLEAnca D Askanase, Wei Tang, Qing Zuraw, Robert Gordon, Betsy Brotherton, Joan T Merrill
3 April 2023
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus CohortManuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Mariela Medina, Claudia Elera-Fitzcarrald, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Risto Alfredo Perich-Campos, Graciela S Alarcón
14 February 2023
Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort studyRory C Monahan, Liesbeth J J Beaart-van de Voorde, Rolf Fronczek, Jeroen de Bresser, Jeroen Eikenboom, Margreet Kloppenburg, Huub A M Middelkoop, Gisela M Terwindt, Nic J A van der Wee, Tom W J Huizinga, Gerda M Steup-Beekman
3 February 2023
Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve studyJacob N Hunnicutt, Jolyon Fairburn-Beech, Mary Elizabeth Georgiou, Anna Richards, Yun Irene Gregan, Holly Quasny, Deven Chauhan
30 November 2022
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquineCelline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle A Petri, Ellen M Ginzler, Daniel J Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary-Anne Dooley, Christine Peschken, David IsenbergSee the full list of authors
17 November 2022
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemicFrancesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Y Choi, Murray B Urowitz, Guillermo Ruiz-Irastorza, Sasha Bernatsky, Daniel J Wallace, Michelle A Petri, Susan Manzi, Sang-Cheol Bae, Jung-Min Shin, Anselm Mak, Jiacai ChoSee the full list of authors
25 October 2022
Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional studyKen-ei Sada, Yu Katayama, Yosuke Asano, Keigo Hayashi, Yoshia Miyawaki, Keiji Ohashi, Eri Katsuyama, Takayuki Katsuyama, Mariko Takano-Narazaki, Yoshinori Matsumoto, Ryusuke Yoshimi, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro IchinoseSee the full list of authors
27 September 2022
Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?Melissa J Fazzari, Marta M Guerra, Jane Salmon, Mimi Y Kim
14 September 2022
